Skip to content
Disclosery

EXANE DERIVATIVES: MAS position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on MAS, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 2,976 MAS shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 2,976 shares
    Change vs previous 13F -7,502 shares

    0.09% of the 13F portfolio, value $150,570.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 10,478 shares
    Change vs previous 13F +5,639 shares

    0.15% of the 13F portfolio, value $534,382.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 4,839 shares
    Change vs previous 13F -63 shares

    0.08% of the 13F portfolio, value $339,806.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 4,902 shares
    Change vs previous 13F +517 shares

    0.07% of the 13F portfolio, value $272,315.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 4,385 shares
    Change vs previous 13F +2,987 shares

    0.06% of the 13F portfolio, value $255,913.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 1,398 shares
    Change vs previous 13F +1,297 shares

    0.03% of the 13F portfolio, value $83,743.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 101 shares
    Change vs previous 13F -1,293 shares

    <0.01% of the 13F portfolio, value $5,548.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 1,394 shares
    Change vs previous 13F not available

    0.03% of the 13F portfolio, value $76,852.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).